Combination of Talazoparib and Calcitriol Enhanced Anticancer Effect in Triple−Negative Breast Cancer Cell Lines

Combination of Talazoparib and Calcitriol Enhanced Anticancer Effect in Triple−Negative Breast Cancer Cell Lines

Monotherapy for triple−negative breast cancer (TNBC) is often ineffective. This study aimed to investigate the effect of calcitriol and talazoparib combination on cell proliferation, migration, apoptosis and cell cycle in TNBC cell lines. Monotherapies and their combination were studied for (i.) ant...

Full description

Bibliographic Details
Main Authors: Fu Hou Wong, Vijayaraj Kumar Palanirajan, Edmond Siah Chye Ng, Chung Keat Tan, Eugenie Sin Sing Tan, Farahnaz Amini
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Pharmaceuticals
Subjects:
anticancer effect
breast cancer
calcitriol
combined therapy
talazoparib
TNBC
Online Access:https://www.mdpi.com/1424-8247/15/9/1075

Internet

https://www.mdpi.com/1424-8247/15/9/1075

Similar Items